A recombinant rabbit monoclonal antibody against PMS2 and its application

By preparing a highly specific and sensitive recombinant rabbit monoclonal antibody against PMS2, the problem of insufficient specificity and sensitivity in the detection of PMS2 protein in the existing technology was solved, and a more accurate immunohistochemical detection effect was achieved.

CN118620075BActive Publication Date: 2024-12-06SUZHOU BAIDAO MEDICAL TECH CO LTD +1
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411106772.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-12-06
Estimated Expiration
2044-08-13

AI Technical Summary

Technical Problem

Existing commercially available PMS2 antibodies have insufficient binding specificity and sensitivity to PMS2 protein molecules, resulting in poor identification in immunohistochemical detection and difficulty in accurately identifying PMS2 protein expression.

Method used

A recombinant rabbit monoclonal antibody against PMS2 was developed. By immunizing rabbits with a specific polypeptide antigen, a hybridoma cell line that secretes monoclonal antibodies was obtained. The heavy and light chain amino acid sequences were obtained using molecular cloning technology. A eukaryotic expression vector was constructed and transfected into 293 cells. The antibody with high specificity and high sensitivity was purified and applied to immunohistochemical detection.

Benefits of technology

This method achieves high specificity and high sensitivity in the recognition of PMS2 protein, improving the accuracy and identification of immunohistochemical detection, especially in the differentiation of cancer.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118620075B_ABST
    Figure CN118620075B_ABST
Patent Text Reader

Abstract

The present invention relates to an anti-PMS2 recombinant rabbit monoclonal antibody and its application, comprising a heavy chain variable region and a light chain variable region, wherein the amino acid sequence of the heavy chain variable region is shown in SEQ ID No. 4; and the amino acid sequence of the light chain variable region is shown in SEQ ID No. 5. The anti-PMS2 recombinant rabbit monoclonal antibody provided by the present invention has high affinity with PMS2 protein, can identify and detect the expression of PMS2 protein on tumor cells or immune cells with high specificity and high sensitivity, can be applied to detection and screening fields such as immunohistochemistry, indirect ELISA, immunoblotting, antibody chip preparation, etc., is conducive to obtaining more accurate detection and evaluation results, and reducing detection costs and interference of background signals.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of immunochemistry, and in particular relates to an anti-PMS2 recombinant rabbit monoclonal antibody and an application thereof, in particular to an application in immunohistochemical detection. Background Art

[0002] PMS2 is a 96 kDa mismatch repair protein that forms a heterodimer with the PMS2 protein, which is then activated in the presence of ATP; this complex coordinates the binding of other proteins that repair DNA errors that occur during cell division. Loss of PMS2 expression in tumor cells helps identify HPMS2 mutation carriers and determine if they are suitable for mutation analysis. Defects in the PMS2 gene are responsible for a small but significant proportion of colorectal cancers and the majority of tumors with microsatellite instability. PMS2 has been associated with cases of the dominantly inherited disease hereditary nonpolyposis colorectal cancer (HNPCC) and is often used in tumor research along with PMS2, MSH2, and MSH6.

[0003] The binding specificity and sensitivity of currently available PMS2 antibodies to PMS2 protein molecules need to be improved, and the recognition is poor in IHC staining, which is not conducive to the detection and differentiation of cancer, resulting in limited application areas of currently available PMS2 antibodies. Summary of the invention

[0004] 1. Technical issues to be resolved

[0005] In view of the above-mentioned shortcomings and deficiencies of the prior art, the present invention provides an anti-PMS2 recombinant rabbit monoclonal antibody and its application which has wide application and can accurately identify the expression of PMS2. The present invention also relates to a nucleotide sequence encoding the anti-PMS2 recombinant rabbit monoclonal antibody, a recombinant plasmid or an expression vector, a preparation method, and the application of the anti-PMS2 recombinant rabbit monoclonal antibody in a PMS2 protein detection method or device.

[0006] (II) Technical solution

[0007] In order to achieve the above object, the main technical solutions adopted by the present invention include:

[0008] In a first aspect, the present invention provides an anti-PMS2 recombinant rabbit monoclonal antibody, which comprises a heavy chain variable region and a light chain variable region, wherein the amino acid sequence of the heavy chain variable region is shown in SEQ ID NO:4; and the amino acid sequence of the light chain variable region is shown in SEQ ID NO:5.

[0009] This anti-PMS2 recombinant rabbit monoclonal antibody (PMS2 rabbit antibody) can be used for immunohistochemical detection, and can identify and detect the expression of PMS2 protein on tumor cells or immune cells with high specificity and sensitivity.

[0010] The anti-PMS2 monoclonal antibody is obtained by recombinant expression of mammalian cells. Specifically, the anti-PMS2 recombinant rabbit monoclonal antibody provided by the present invention is produced by rabbit hybridoma fusion screening and 293 cell eukaryotic expression. When preparing the anti-PMS2 monoclonal antibody, the antigen used to immunize the rabbit (New Zealand white rabbit) is a synthetic polypeptide, and the amino acid sequence of the synthetic polypeptide is shown in SEQ ID NO: 1, which is obtained by artificial chemical synthesis. After immunizing the rabbit, a positive hybridoma cell line that can efficiently secrete monoclonal antibodies is obtained through cell fusion and cloning screening, and the nucleotide sequence encoding the heavy chain amino acid sequence and light chain amino acid sequence of the antibody is obtained by molecular cloning technology. The nucleotide sequence is constructed on a eukaryotic expression vector, transfected into a 293 cell line by a transfection reagent, and the cell supernatant is collected. Purify the cell supernatant by protein A column affinity chromatography to obtain a rabbit monoclonal antibody. Immunohistochemical detection shows that the antibody can specifically recognize PMS2 protein.

[0011] The anti-PMS2 monoclonal antibody can recognize recombinant PMS2 antigen protein and PMS2 molecules on tumor cells and immune cells; the anti-PMS2 monoclonal antibody can also be used in immunohistochemical pathological diagnostic agents.

[0012] In a second aspect, the present invention provides a coding gene for encoding the above-mentioned anti-PMS2 recombinant rabbit monoclonal antibody.

[0013] Preferably, the encoding gene includes a DNA sequence as shown in SEQ ID NO:2 or a sequence complementary thereto, which is used to encode the heavy chain variable region of the anti-PMS2 recombinant rabbit monoclonal antibody; and a DNA sequence as shown in SEQ ID NO:3 or a sequence complementary thereto, which is used to encode the light chain variable region of the anti-PMS2 recombinant rabbit monoclonal antibody.

[0014] In a third aspect, the present invention provides a nucleic acid molecule comprising a gene encoding the anti-PMS2 recombinant rabbit monoclonal antibody.

[0015] In a fourth aspect, the present invention provides an expression vector or a recombinant plasmid, which comprises the above-mentioned nucleic acid molecule.

[0016] In a fifth aspect, the present invention provides a host cell transformed or transfected with the above-mentioned expression vector or recombinant plasmid.

[0017] In a sixth aspect, the present invention provides a method for preparing an anti-PMS2 recombinant rabbit monoclonal antibody, comprising transforming or transfecting the above-mentioned host cells using the above-mentioned expression vector or recombinant plasmid, culturing the transformed or transfected cells, collecting and purifying the cell supernatant, and obtaining the anti-PMS2 recombinant rabbit monoclonal antibody.

[0018] In a seventh aspect, the use of the anti-PMS2 recombinant rabbit monoclonal antibody, encoding gene, nucleic acid molecule, expression vector or recombinant plasmid in the preparation of a PMS2 protein molecule detection device. The detection device includes but is not limited to a kit, an antibody chip, and the like.

[0019] In an eighth aspect, the present invention further provides a PMS2 detection kit, which comprises the above-mentioned anti-PMS2 recombinant rabbit monoclonal antibody and an immunohistochemical detection reagent.

[0020] Preferably, the PMS2 detection kit comprises: anti-PMS2 recombinant rabbit monoclonal antibody, horseradish peroxidase labeled secondary antibody, ethylenediaminetetraacetic acid repair solution, catalase blocking solution, 3,3'-diaminobenzidine concentrate, 3,3'-diaminobenzidine buffer, hematoxylin and bluing solution.

[0021] When performing immunohistochemistry detection, the detection steps include dewaxing, antigen retrieval, endogenous peroxidase inactivation, blocking, primary antibody incubation, secondary antibody incubation, 3,3'-diaminobenzidine (DAB) color development, counterstaining, dehydration, sealing and microscopic examination.

[0022] (III) Beneficial effects

[0023] The anti-PMS2 recombinant rabbit monoclonal antibody provided by the present invention has high specificity and high sensitivity in binding to the PMS2 protein molecule, can specifically identify and detect the expression of PMS2 protein on cells, and is positively highly expressed when detecting PMS2 protein. After immunohistochemical detection of various different tissues, it is found that the antibody can be applied to immunohistochemistry (IHC), indirect enzyme-linked immunosorbent assay (ELISA), Western blotting, antibody chip preparation, flow cytometry and other detection and screening fields, which is conducive to obtaining accurate evaluation and detection results. The PMS2 recombinant rabbit monoclonal antibody cloned by 157G1F5 of the present invention is easier to score in IHC staining due to its good specificity and strong positive signal, and is more accurate for detecting and distinguishing cancer. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1The present invention provides immunohistochemical detection results of the 157G1F5 anti-PMS2 monoclonal antibody prepared by the present invention and commercially available antibodies in tonsil, colon cancer, and gastric cancer tissues. The concentration of the 157G1F5 anti-PMS2 monoclonal antibody used is 1 μg / mL; wherein a is an immunohistochemical detection result of the 157G1F5 cloned PMS2 antibody in tonsil, and b is an immunohistochemical detection result of the commercially available antibody in tonsil (a and b have the same magnification); c is an immunohistochemical detection result of the 157G1F5 cloned PMS2 antibody in colon cancer, and d is an immunohistochemical detection result of the commercially available antibody in colon cancer (c and d have the same magnification); e is an immunohistochemical detection result of the 157G1F5 cloned PMS2 antibody in gastric cancer tissue, and f is an immunohistochemical detection result of the commercially available antibody in gastric cancer tissue (e and f have the same magnification);

[0025] Figure 2 It is a statistical graph of the titer detection of the 157G1F5 anti-PMS2 monoclonal antibody of the present invention and commercially available antibodies at 8 gradient concentrations;

[0026] Figure 3 The immunoblotting (Western blotting) test results of the 157G1F5 anti-PMS2 monoclonal antibody of the present invention as a primary antibody verify its recognition ability for the PMS2 protein. DETAILED DESCRIPTION

[0027] To further illustrate the technical means and effects of the present invention, the present invention is further described below in conjunction with the embodiments and drawings. It should be understood that the specific implementation methods described herein are only used to explain the present invention, rather than to limit the present invention.

[0028] If no specific technology or conditions are specified in the examples, the technology or conditions described in the literature in the field or the product instructions are used. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased through regular channels. Human tissue samples are formalin-fixed and paraffin-embedded human tissue samples, all of which have been pathologically confirmed and have informed consent from patients.

[0029] Example 1

[0030] This example is the preparation and screening of anti-PMS2 recombinant rabbit monoclonal antibodies, and the steps include:

[0031] (1) Antigen preparation

[0032] The specific sequence of PMS2 antigen is shown as SEQ ID NO: 1 below.

[0033] SEQ ID NO: 1 is: CVSDNGCGVEEENFEGLT

[0034] The above polypeptide sequence is selected by analyzing the PMS2 molecular sequence based on the structure, antigenicity, hydrophilicity and secondary structure of the PMS2 protein molecule. The polypeptide of the sequence shown in SEQ ID NO:1 is artificially synthesized, and the synthesized polypeptide is used as an antigen for immunizing rabbits. During immunization, the polypeptide of the sequence shown in SEQ ID NO:1 is coupled to hemocyanin (KLH) and used as a PMS2 antigen to immunize rabbits.

[0035] (2) Immunity

[0036] The PMS2 antigen obtained in step (1) was mixed and emulsified with complete Freund's adjuvant (volume ratio 1:1), and multiple New Zealand white rabbits were immunized by subcutaneous injection. After an interval of two weeks, the PMS2 antigen containing the above sequence (the polypeptide shown in SEQ ID NO:1) was emulsified with incomplete Freund's adjuvant (volume ratio 1:1) for the second and third immunizations. After the three immunizations, blood was collected and the serum titer was determined by gradient dilution by ELISA; the rabbit with the highest antibody titer immunized with the SEQ ID NO:1 antigen was selected for the next step of cell fusion.

[0037] (3) Cell fusion

[0038] Prepare mouse-derived sp2 / 0 myeloma cells in advance so that the sp2 / 0 myeloma cells are in the logarithmic growth phase during fusion. Take the spleen of an immunized rabbit and prepare a single-cell suspension of lymphocytes; mix the rabbit spleen lymphocytes with the myeloma cells, add 50% PEG1500 dropwise, add IMDM culture medium, centrifuge and discard the supernatant, add HAT culture medium and gently suspend and mix, fix the volume to 800 mL, and then divide into 96-well plates and place in a 37°C, 5% CO2 constant temperature incubator for culture. After 6-9 days of fusion, observe the state of the fused cells in the 96-well plate, replace the medium with HT and continue to culture in a 37°C, 5% CO2 constant temperature incubator.

[0039] (4) Screening and cloning

[0040] 7-10 days after fusion, use PMS2 antigen (SEQ ID NO: 1) to perform ELISA test to screen cloned cells. Mark the corresponding cell line number, and perform limiting dilution on the positive well cells until the ELISA test results of the 96-well plate are positive. Select the monoclonal stable strain with high positive value to obtain the hybridoma cell line that secretes specific monoclonal antibodies, which is recorded as 157G1F5.

[0041] (5) Perform antibody sequencing on the selected hybridoma cell lines

[0042] According to the instructions of TriZol RNA extraction reagent, total RNA was isolated from 157G1F5 hybridoma cells, and according to the instructions of TIANScript first-strand cDNA synthesis kit, the total RNA was reverse transcribed into cDNA, and the nucleotide sequences of the antibody heavy chain variable region and the antibody light chain variable region were amplified using specific primers (heavy chain variable region primer, VH-F: AGACTGGGCTGCGCTGGCTTC, VH-R GTGAGGGTGCCCGAG; light chain variable region primer: VK-F ATGGACAYGAGGGCCCCCACTC, VK-R: GGTGGGAAGATGAGGACAGTAGG), and then the nucleotide sequences of the antibody heavy chain variable region and the antibody light chain variable region were cloned into eukaryotic expression vectors (InvivoGen, pfuse-rchg, pfuse2-rclk1) in preparation for cell transfection.

[0043] (6) Cell transfection and screening

[0044] Prepare the 293 cells to be transfected in advance, centrifuge and replace with fresh culture medium, and place them in 24-well plates, with 1.5 ml per well according to the required number, and the density is 3×10 6 Pieces / ml.

[0045] The eukaryotic expression vector and polyethyleneimine (PEI) were mixed at a mass ratio of 1:6 and added to the prepared 293 cells, and cultured in a shaker at 37°C and 5% CO2. After culturing for 3-5 days, the transfected cell supernatant was tested with the corresponding antigen by ELISA to screen the positive wells, and then the cell supernatant of the positive wells was further tested by immunohistochemistry. If the immunohistochemistry test was positive, it was confirmed that the detected antibody sequence was correct.

[0046] (7) Preparation and purification of monoclonal antibodies on cells

[0047] The positive expression vectors were transfected into a large number of cells, and after 3-5 days of continuous culture, the cell suspension was collected, the supernatant was taken after centrifugation, and the supernatant was purified by affinity chromatography using protein A to obtain antibodies with a purity of >95%. The purified monoclonal antibody concentration was measured, packaged, and stored in a refrigerator at 4-8°C.

[0048] Finally, the nucleotide sequence of the heavy chain variable region of the 157G1F5 anti-PMS2 recombinant rabbit monoclonal antibody is shown in SEQ ID No. 2, and the nucleotide sequence of the light chain variable region of the anti-PMS2 recombinant rabbit monoclonal antibody is shown in SEQ ID NO:3.

[0049] The specific sequences of SEQ ID NO:2 and SEQ ID NO:3 are as follows:

[0050] SEQ ID NO:2 is:

[0051] cagtcggtggaggagtccgggggtcgcctggtaacgcctgggacacccctgacactcacctgcacagtctctggagtcgacctcagtagcgatgcagtgagctgggtccgccaggctccaggaaaggggctggaatacatcggagccattggtagtagtggtaacacatac tacgcgaactgggcgaaaggccgattcaccatctccaaaacctcgtcgaccacggtggatctgagaatcaccagtccgacaaccggggacacggccacctatttctgtgccataggggctgttagtggaactattgtctggggcccaggcaccctggtcaccgtctcctca

[0052] SEQ ID NO:3 is:

[0053] gcgcaagtgctgacccagactgcatcgtccgtgtctgcagctgtgggaggcacagtcaccatcagttgccagtccagtgagagtgtcaataataatcggttaggctggtatcagcagaaaccagggcagcctcccaagctcctgatctatggtgcatccactc tggcatctggggtcccatcgcggttcagtggcagtgggtctgggacacagttcactctcaccatcagcgacctggagtgtgacgatgctgccacttattattgtgcaggcgcttatagtggtaatatttttgatttcggtggagggaccgaggtggtggtcaaa

[0054] The obtained base sequence was translated into an amino acid sequence and analyzed to obtain the amino acid sequence of the heavy chain variable region of the 157G1F5 anti-PMS2 recombinant rabbit monoclonal antibody as shown in SEQ ID NO:4, and the amino acid sequence of the light chain variable region of the anti-PMS2 recombinant rabbit monoclonal antibody as shown in SEQ ID NO:5.

[0055] The specific sequences of SEQ ID NO:4-5 are as follows:

[0056] SEQ ID NO:4 is:

[0057] QSVEESGGRLVTPGTPLTLTCTVSGVDLSSDAVSWVRQAPGKGLEYIGAIGSSGNTYYANWAKGRFTISKTSSTTVDLRITSPTTGDTATYFCAIGAVSGTIVWGPGTLVTVSS

[0058] SEQ ID NO:5 is:

[0059] AQVLTQTASSVSAAVGGTVTISCQSSESVNNNRLGWYQQKPGQPPKLLIYGASTLASGVPSRFSGSGSGTQFTLTISDLECDDAATYYCAGAYSGNIFDFGGGTEVVVK

[0060] Example 2

[0061] This example is an immunohistochemical detection using anti-PMS2 recombinant rabbit monoclonal antibody as the primary antibody, and the method is as follows:

[0062] (1) Sample slice preparation: Formalin-fixed, paraffin-embedded tonsil, colon cancer, and gastric cancer tissue slices were baked in a 60°C incubator for 1-2 h and stored for later use;

[0063] (2) Dewaxing of sections: Paraffin sections are first dewaxed in fresh xylene, soaking twice for 10 min each time;

[0064] (3) Hydration of sections: Soak in anhydrous ethanol, anhydrous ethanol, 95% ethanol, 85% ethanol, and 70% ethanol for 5 minutes in sequence for hydration, and then rinse with purified water twice, 3 minutes each time;

[0065] (4) Antigen repair: It is recommended to use high temperature heat repair method for 3 minutes (if using an automatic repair instrument, set the temperature to 98°C for 20 minutes). After the slices are naturally cooled to room temperature, circle the tissue to be tested with an immunohistochemistry pen and rinse with purified water twice, 3 minutes each time;

[0066] (5) Inactivation of endogenous peroxidase: drop an appropriate amount of endogenous peroxidase blocker to completely cover the tissue, incubate at room temperature for 10 min, rinse twice with purified water, 3 min each time, and rinse once with phosphate buffered saline (PBST);

[0067] (6) Primary antibody incubation: Add 100 μL of 1 μg / mL 157G1F5 anti-PMS2 recombinant rabbit monoclonal antibody to completely cover the tissue, incubate in a 37°C incubator for 1 h, and rinse with PBST three times, 5 min each time;

[0068] (7) Secondary antibody incubation: Perform secondary antibody incubation according to the instructions of the DAB staining solution kit of the secondary antibody staining system used. After incubation, rinse the slides three times with PBST, each time for 5 minutes, and rinse once with purified water;

[0069] (8) DAB staining: Prepare DAB staining solution according to the instructions of the DAB staining solution kit. Add an appropriate amount of DAB staining solution until the tissue is completely covered. Stop staining when the color does not deepen. Rinse with purified water three times.

[0070] (9) Hematoxylin counterstaining: Counterstain the sections according to the hematoxylin manufacturer's instructions and recommendations, and rinse with PBST or tap water to return to blue;

[0071] (10) Dehydration and transparency: Soak in 70%, 85%, 95%, 100%, and 100% alcohol in sequence, 3 min each time; and transparentize in xylene twice, 5 min each time;

[0072] (11) Sealing: Seal the samples with neutral gum.

[0073] Depend on Figure 1 The results show that PMS2 protein shows specific nuclear staining in human tonsil, colon cancer, and gastric cancer tissues, and the staining effect of the PMS2 recombinant rabbit monoclonal antibody cloned from 157G1F5 is better than that of the commercially available PMS2 antibody, and the staining color is darker. This shows that the PMS2 recombinant rabbit monoclonal antibody cloned from 157G1F5 of the present invention is easier to evaluate in IHC staining, has high recognition, and is more accurate in detecting and distinguishing cancers due to its good specificity and strong positive signal.

[0074] Example 3

[0075] This example is a determination of the affinity of the 157G1F5 anti-PMS2 recombinant rabbit monoclonal antibody, and the determination method is as follows:

[0076] (1) Take out the labeled PMS2 polypeptide (SEQ ID NO: 1) from 4°C and return to room temperature. Dilute to a concentration of 1 μg / ml, add 100 μL / well to a 96-well ELISA plate and incubate overnight at 4°C, then block with 2% bovine serum albumin (BSA) at 4°C overnight;

[0077] (2) The PMS2 recombinant rabbit monoclonal antibody cloned from 157G1F5 was diluted to an initial concentration of 0.5 μg / mL, and then diluted 2-fold in sequence, with a total of 8 concentration gradients for comparison;

[0078] (3) Add the diluted anti-PMS2 recombinant rabbit monoclonal antibody to the 96-well ELISA plate containing the peptide at 100 μL / well, cover with a sealing film, and incubate at 37°C for 1 h to allow the reaction to reach equilibrium;

[0079] (4) After the reaction is completed, remove the ELISA plate, discard the liquid, rinse it with purified water 5 times, and pat dry;

[0080] (5) Dilute horseradish peroxidase (HRP)-labeled goat anti-rabbit IgG according to the instructions for use of the secondary antibody, add 100 μL / well to the ELISA plate, and incubate at 37°C for 1 h to allow the reaction to reach equilibrium;

[0081] (6) After the reaction is completed, remove the ELISA plate, discard the liquid, rinse it with purified water 5 times, and pat dry;

[0082] (7) Add 3,3',5,5'-tetramethylbenzidine (TMB) colorimetric solution at 100 μL / well and react at room temperature for 6 minutes;

[0083] (8) After the reaction is completed, add 2M H2SO4 at 50 μL / well to stop the color development;

[0084] (9) Read the OD value at 450 nm on an ELISA reader and organize the data. The analysis results are as follows: Figure 2 shown.

[0085] The results showed that in 8 concentration gradient tests, the anti-PMS2 recombinant rabbit monoclonal antibody cloned by 157G1F5 of the present invention had a strong affinity and high sensitivity to the PMS2 protein molecule, and could still achieve a high OD value under conditions of lower antibody concentrations, thereby saving experimental and detection costs.

[0086] Example 4

[0087] This example is a Western blotting test using the anti-PMS2 recombinant rabbit monoclonal antibody 157G1F5 as the primary antibody, and the method is as follows:

[0088] (1) Activate the polyvinylidene fluoride (PVDF) membrane of NIH / 3T3 cell lysate with methanol for 1 min, wash the membrane twice with pure water and then wash it three times with TBST; Block: Place the membrane in a blocking solution prepared with 5% bovine serum albumin (BSA) and shake it at room temperature for 2 h; TBST is a commonly used washing buffer suitable for experiments such as immunoblotting. It contains three basic components: Tris buffer, salt (usually sodium chloride), and surfactant Tween-20;

[0089] (2) Primary antibody incubation: dilute the 157G1F5 antibody to a concentration of 0.5 μg / mL, place the blocked membrane in the corresponding diluted antibody, and incubate at 4°C with shaking overnight;

[0090] (3) Take out the membrane and wash it in TBST solution for 3 times (2×5min+1×10min);

[0091] (4) Secondary antibody incubation: dilute HRP-anti-rabbit IgG with FG solution at 1:5000, mix well, add to the membrane strip, and shake at room temperature for 1 h;

[0092] (5) Take out the membrane strip and wash it in TBST solution for 4 times (3×5min+1×8min);

[0093] (6) Substrate: Mix equal amounts of luminol / enhancer solution and hydrogen peroxide solution diluted 5-fold with pure water in the same container, add to the membrane strips, and incubate for 2 min.

[0094] (7) Exposure: Place the film in a dark box and expose it to X-rays for different time periods according to the fluorescence intensity. Then, develop it for 1 minute, wash it, and fix it for 1 minute. Finally, wash it and dry it. The results are as follows: Figure 3 shown.

[0095] The theoretical molecular weight of PMS2 protein is about 96 kDa. Due to phosphorylation modification of PMS2 protein, the actual measured molecular weight will be greater than the theoretical value. In order to compare the band size of PMS2 protein, the present invention also provides the band size of PMS2 protein in the known Hela. Figure 3 Hela represents human cervical cancer cell lysate, and NIH / 3T3 represents mouse embryonic fibroblast lysate. Figure 3 The results show that the band size of the PMS2 protein in NIH / 3T3 is consistent with that in Hela. That is, in the lane, the 157G1F5 anti-PMS2 recombinant rabbit monoclonal antibody can specifically recognize the PMS2 protein in mouse embryonic fibroblasts, indicating that the 157G1F5 cloned PMS2 recombinant rabbit monoclonal antibody of the present invention can highly specifically recognize the PMS2 protein.

[0096] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. An anti-PMS2 recombinant rabbit monoclonal antibody, characterized in that: It comprises a heavy chain variable region and a light chain variable region, wherein the amino acid sequence of the heavy chain variable region is shown in SEQ ID NO:4; and the amino acid sequence of the light chain variable region is shown in SEQ ID NO:

5.

2. A coding gene, characterized in that Used to encode the anti-PMS2 recombinant rabbit monoclonal antibody according to claim 1.

3. The coding gene according to claim 2, characterized in that It includes: The DNA sequence as shown in SEQ ID NO:2 is used to encode the heavy chain variable region of the anti-PMS2 recombinant rabbit monoclonal antibody, and the DNA sequence as shown in SEQ ID NO:3 is used to encode the light chain variable region of the anti-PMS2 recombinant rabbit monoclonal antibody.

4. A nucleic acid molecule, characterized in that It contains the coding gene according to claim 2 or 3.

5. An expression vector or recombinant plasmid, characterized in that: It contains the nucleic acid molecule according to claim 4.

6. A host cell transformed or transfected with the expression vector or recombinant plasmid according to claim 5.

7. A method for preparing an anti-PMS2 recombinant rabbit monoclonal antibody, characterized in that: The host cell according to claim 6 is transformed or transfected with the expression vector or recombinant plasmid according to claim 5, the transformed or transfected cells are cultured, and the cell supernatant is collected and purified to obtain the anti-PMS2 recombinant rabbit monoclonal antibody.

8. Use of the anti-PMS2 recombinant rabbit monoclonal antibody according to claim 1, the encoding gene according to claim 2 or 3, the nucleic acid molecule according to claim 4, the expression vector or recombinant plasmid according to claim 5, and the host cell according to claim 6 in the preparation of a PMS2 detection device.

9. A PMS2 detection kit, characterized in that: The invention comprises the anti-PMS2 recombinant rabbit monoclonal antibody according to claim 1 and an immunohistochemical detection reagent.

10. The PMS2 detection kit according to claim 9, characterized in that: It includes: The anti-PMS2 recombinant rabbit monoclonal antibody according to claim 1, horseradish peroxidase labeled secondary antibody, ethylenediaminetetraacetic acid repair solution, catalase blocking solution, 3,3'-diaminobenzidine concentrate, 3,3'-diaminobenzidine buffer, hematoxylin and bluing solution.

Citation Information

Patent Citations

  • Methods and systems for evaluation of immune cell infiltrate in stage iv colorectal cancer

    CN113454458A

  • Monoclonal antibody aiming at human mismatch repair protein PMS2, preparation method thereof, immunodetection reagent and application

    CN114213533A